Breast Cancer Clinical Trial
— LABSOfficial title:
Lymphatic Mapping After Previous Breast Surgery
NCT number | NCT01164748 |
Other study ID # | NL22080.060.08 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | July 16, 2010 |
Last updated | July 16, 2010 |
Rationale: Like in primary breast cancer, prognosis in recurrent breast cancer is correlated
with regional lymph node status. Therefore, axillary staging may be warranted in patients
with recurrent disease and intact axillary nodes, although this has not been described in
guidelines yet. The lymphatic drainage pathways in the breast and/or axilla could have been
changed due to prior surgery and/or radiotherapy. These aberrant drainage pathways could be
detected with lymphatic mapping and sentinel node biopsy (SNB), leading to a more accurate
staging.
Objective: To assess the technical feasibility of lymphoscintigraphy after prior breast
surgery. A second goal is to investigate whether or not previous breast surgery (with or
without radiotherapy) significantly changes the lymphatic drainage pathways of the breast.
Status | Completed |
Enrollment | 0 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - treatment with BCT with SNB and/or ALND for primary breast cancer - previous primary breast cancer located in the upper-outer quadrant of one breast - Primary breast cancer treatment at least 3 years before the analysis, with or without adjuvant chemo- or hormonal therapy. Exclusion Criteria: - breast surgery for other reasons than breast cancer - recurrent breast cancer - former allergic reaction to 99mTc-colloidal albumin. |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Netherlands | Catharina Hospital | Eindhoven |
Lead Sponsor | Collaborator |
---|---|
Catharina Ziekenhuis Eindhoven |
Netherlands,
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |